首页|期刊导航|生物医学研究杂志（英文版）|Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis

Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis

Fei Qin Hao Yu Changrong Xu Huihui Chen Jianling Bai

生物医学研究杂志（英文版）2018，Vol.32Issue(1)：30-38,9.

Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis

Fei Qin ¹Hao Yu ¹Changrong Xu ¹Huihui Chen ¹Jianling Bai¹

作者信息

1. Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
折叠

摘要

关键词

axitinib/sorafenib/safety/renal cell carcinoma/meta-analysis

Key words

axitinib/sorafenib/safety/renal cell carcinoma/meta-analysis

分类

医药卫生

引用本文复制引用

Fei Qin,Hao Yu,Changrong Xu,Huihui Chen,Jianling Bai..Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis[J].生物医学研究杂志（英文版）,2018,32(1):30-38,9.

基金项目

The work was supported by grants from the National Natural Science Foundation of China (81773554 to H.Yu),and the National Natural Science Foundation of China Grant for Young Scientists (81302512 to J.Bai). （81773554 to H.Yu）

生物医学研究杂志（英文版）

OACSCD

ISSN：1674-8301

访问量2

下载量0

段落导航